Nelcast (NELCAST)

FairStock Score: 41/100 — MIXED

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Promoter holding of 74.87% aligns promoter interests with minority shareholders.
• Sales growth of 13.11% and latest quarterly net profit of ₹16 Cr show near-term operating momentum.
• Piotroski F-score of 7/9 indicates improving financial health and lower distress risk.
• PEG of 0.24 appears optically cheap if one trusts the recent earnings jump as a growth base.

Concerns

• Low ROE of 8.76% and ROCE of 9.55% suggest weak capital efficiency and limited moat.
• Price of ₹130.30 is 2.41x book value of ₹54.01, leaving little margin of safety for a cyclical manufacturer.
• P/E of 21.33 combined with 165.89% profit growth may be pricing peak cyclical earnings rather than normalised profits.
• Dividend yield of just 0.44% offers negligible income support to shareholders.

AI Analysis

At ₹130.30, Nelcast is asking me to pay roughly 21 times earnings and 2.4 times book value. That is not a bargain price for a casting company earning only 8.76% on equity and 9.55% on capital employed. Graham would want a margin of safety; I don't see one when the share is already well above its 52-week low of ₹85.98. The 165.89% profit growth and PEG of 0.24 attract attention, but in cyclical casting businesses, peak earnings are the wrong basis for valuation. A 13.11% sales rise is decent, yet profitability remains moderate. The latest quarter's ₹16 Cr net profit on ₹330 Cr sales is helpful, but I need a longer runway before calling this a high-quality compounder. Positives: 74.87% promoter ownership, a Piotroski score of 7/9, and improving operating momentum are good signs. The company may be recovering from a difficult period, and the F-score suggests strengthening financials. But the price already reflects much of that hope. Book value is ₹54.01, so the stock trades at a huge premium to asset value; for a fairly commoditised castings business, that premium requires a durable, high return on equity to justify it, and I simply don't see that yet. I would place Nelcast in the cyclical basket: attractive when normalized earnings are low, but not compelling after a 165% earnings pop. The dividend yield is negligible at 0.44%. I would watch whether margins, cash flow, and demand can sustain this recovery. If the next few quarters keep profits near ₹16 Cr, the P/E will look cheaper, but investing today requires a cyclical lens, not a growth-at-any-price one.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer